Following Increase in Tuberculosis Cases in Ohio, Brown Calls on Obama Administration to Fully Fund Efforts to Eliminate Deadly Disease

There were 49 Cases of Tuberculosis in Franklin County in 2014 – the Highest in State; Number of Tuberculosis Cases in Ohio Increased from 2013 to 2014

COLUMBUS, OH – Following an increase in Tuberculosis cases in Ohio, U.S. Sen. Sherrod Brown (D-OH) joined public health officials in Columbus today to call for full funding of efforts to eliminate this deadly disease. In 2014, there were 49 cases of tuberculosis in Franklin County alone – the highest of any county in the state.

“When diseases in other nations are never more than a plane ride away, we need to do more to keep Ohioans safe from the threat of tuberculosis,” Brown said. “Eradicating tuberculosis requires more funding, not less. While I am pleased with the Administration’s new initiative to combat drug-resistant TB, we cannot expect progress if we don’t dedicate adequate resources that are so important to this effort—without funding, this will be just another plan on a shelf.”

Brown joined Dr. Teresa Long, Columbus Public Health Commissioner, and Dr. Mysheika Roberts, Columbus Public Health Assistant Commissioner and Medical Director, who outlined the need to direct additional resources to eradicate multidrug-resistant tuberculosis (MDR-TB).

“TB can strike at any time, while we think of it as a disease that strikes those far away, it can affect us right here at home. It is not a matter of if, but when. We must ensure that funding is available now, so we can fulfill our mission and protect the public’s health,” says Dr. Teresa C. Long.

Tuberculosis has caused more deaths than any other single infectious disease worldwide, killing more than 1.5 million people each year. Although there has been a global reduction in tuberculosis deaths since 1990, more than 4,000 people continue to die from this disease every day. In Ohio, the number of tuberculosis cases increased from 148 in 2013 to 156 in 2014.

Following Brown’s call, President Obama recently announced the Administration’s National Action Plan for combating MDR-TB.  The plan lays out a comprehensive strategy to both mobilize political will and seek additional financial and in-kind commitments from public health, private-sector partners, and governments of all affected countries. It is now important that this plan receive robust funding, so that it can become a reality.

This week, Brown will lead several of his Senate colleagues in sending a letter to President Obama urging him to fully fund this plan by providing robust funding federal TB programs. Full text of the letter is below.


President Barack Obama

1600 Pennsylvania Ave. NW

Washington, DC 20500


Dear Mr. President,


We write in support of the Administration’s final National Action Plan to Address Drug-Resistant Tuberculosis (National Action Plan). The launch of this robust, comprehensive plan to combat multidrug-resistant tuberculosis (MDR-TB) is a strong start toward addressing the threat of tuberculosis both at home and abroad, and we urge you to include sufficient funding for this plan in the President’s Budget for Fiscal Year 2017 (FY17).


Tuberculosis (TB) has caused more deaths than any other single infectious disease killing more than 1.5 million people each year. In 2014, there were more than 9,400 cases of TB in the U.S. alone. Although there has been a global reduction in TB-related deaths since 1990, more than 4,000 people continue to die from TB every day. It is clear that eradicating this disease – both at home and abroad – requires not only additional focus and collaboration, but also additional resources.


The development and implementation of a robust National Action Plan is a critical first step in combatting this deadly disease. We strongly support the three overarching goals of the National Action Plan: 1) to strengthen our domestic capacity to track and treat MDR-TB in the U.S.; 2) to improve our international capacity and collaboration to combat MDR-TB abroad; and 3) to accelerate basic and applied research and development to bolster our efforts to fight this disease. By pooling resources and expertise from multiple government agencies, the National Action Plan provides measurable objectives and sound interventions to end TB deaths. We are particularly pleased with the inclusion of specific targets described in the National Action Plan for addressing MDR-TB in the U.S. and abroad, as well as a set of targeted interventions.


However, the activities described in the National Action Plan are all contingent on receipt of the funding necessary to implement these programs and strengthen our efforts. Implementation of the National Action Plan should be rapid and ambitious. Without an increase in funding, it will be difficult – if not impossible – to quickly execute this plan. This National Action Plan must be accompanied by a funding increase in FY17 for the TB programs at the United States Agency for International Development (USAID) and the Centers for Disease Control and Prevention (CDC). If the spread of MDR-TB is not quickly prevented and controlled, TB-related deaths and treatment costs will increase dramatically – potentially reversing 20 years of progress. We urge you to include the funding necessary to fully implement this robust National Action Plan for the TB programs at USAID and CDC in your FY17 budget.


We applaud the administration for taking the first steps toward a National Action Plan, and look forward to working with you on this priority moving forward.






Sherrod Brown                                                           

U.S. Senator                                                               




CC:     Shaun Donovan, Director, Office of Management and Budget

            Sylvia Mathews Burwell, Secretary, Department of Health and Human Services

            John Kerry, Secretary, Department of State

            Dr. Tom Frieden, Director, Centers for Disease Congrola nd Prevention

Gayle E. Smith, Administrator, United States Agency for International Development

            John P. Holdren, Director, White House Office of Science and Technology